Persistent deficits in hippocampal synaptic plasticity accompany losses of hippocampus-dependent memory in a rodent model of psychosis

Frontiers in Integrative Neuroscience

Volumn , Issue FEBRUARY 2013, 2013, Pages

  Wiescholleck, Valentina ^a,b   Manahan Vaughan, Denise ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b International Graduate School of Neuroscience   (Germany)

Author keywords

Dentate gyrus; In vivo; Long term potentiation; MK801; Schizophrenia

Indexed keywords

DIZOCILPINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CELL COUNT; CELL VIABILITY; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; DISEASE ASSOCIATION; ENTORHINAL CORTEX; HIPPOCAMPUS; HISTOPATHOLOGY; LONG TERM POTENTIATION; MALE; MEMORY; MEMORY DISORDER; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PSYCHOSIS; RAT; RECOGNITION; RETROSPLENIAL CORTEX; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 84874367189     PISSN: 16625145     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnint.2013.00012     Document Type: Article

References (42)

1. Alvarez-Jimenez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Amminger GP et al. (2011). Prediction of a single psychotic episode: a 7.5-year, prospective study in firstepisode psychosis. Schizophr. Res 125(2-3): 236-246.
2. Bender C, de Olmos S, Bueno A, de Olmos J, Lorenzo A (2010). Comparative analyses of the neurodegeneration induced by the non-competitive NMDA-receptor-antagonist drug MK801 in mice and rats. Neurotoxicol Tracol 32(5): 542-50.
3. Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407): 31-39.
4. Canals S, Beyerlein M, Merkle H, Logothetis NK (2009). Functional MRI evidence for LTPinduced neural network reorganization. Curr. Biol 19(5): 398-403.
5. Coyle JT, Tsai G, Goff D. (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci. 1003:318-27.
6. Dawson N, Xiao X, McDonald M, Higham DJ, Morris BJ, Pratt JA (2012) Sustained NMDA Receptor Hypofunction Induces Compromised Systems Integration and Schizophrenia-Like Alterations in Functional Brain Networks. Cereb Cortex. PMID:23081884.
7. Farber, N.B., Wozniak, D.F., Price, M.T., Labruyere, J., Huss, J., St Peter, H. and Olney, J.W. (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry, 38, 788-796.
8. Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, C.A., Long, G.G., Storts, R.W., Farber, N., Wozniak, D.F. and Olney, J.W. (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol, 123, 204-215.
9. Frantseva MV, Fitzgerald PB, Chen R, Möller B, Daigle M, Daskalakis ZJ (2008). Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb. Cortex 18(5): 990-996.
10. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatr 65(4): 446-453.
11. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57(1): 65-73.
12. Gleeson JFM, Alvarez-Jimenez M, Cotton SM, Parker AG, Hetrick S (2010). A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophr. Res 119(1-3): 79-88.
13. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 (Pt 4): 593-624.
14. Harrison PJ (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl.) 174(1): 151-162.
15. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10(1): 40-68.
16. Heckers S, Konradi C (2010). Hippocampal pathology in schizophrenia. Curr Top Behav Neurosci 4: 529-553.
17. Horváth, Z.C., Czopf, J. and Buzsáki, G. (1997) MK-801-induced neuronal damage in rats. Brain Res, 753, 181-195.
18. Kehrer C, Dugladze T, Maziashvili N, Wójtowicz A, Schmitz D, Heinemann U, Gloveli T (2007) Increased inhibitory input to CA1 pyramidal cells alters hippocampal gamma frequency oscillations in the MK-801 model of acute psychosis. Neurobiol Dis. 25:545-52.
19. Korchounov A, Ziemann U (2011). Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study. Neuropsychopharmacology 36(9): 1894-1902.
20. Kornhuber J, Weller M (1997). Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol. Psychiatry 41(2): 135-144.
21. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51(3): 199-214.
22. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001). Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25(4): 455-467.
23. Lindsley CW, Shipe WD, Wolkenberg SE, Theberge CR, Williams DL, Sur C et al (2006). Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem 6(8): 771-785.
24. Lukoyanov, N.V. & Paula-Barbosa, M.M. (2000) A single high dose of dizocilpine produces long-lasting impairment of the water maze performance in adult rats. Neurosci. Lett., 285, 139-142.
25. Manahan-Vaughan D, Haebler D von, Winter C, Juckel G, Heinemann U (2008a). A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 18(2): 125-134.
26. Manahan-Vaughan D, Wildförster V, Thomsen C (2008b). Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Eur. J. Neurosci 28(7): 1342-1350.
27. McGlashan TH (2006). Is active psychosis neurotoxic? Schizophr Bull 32(4): 609-613.
28. Naie K, Gundimi S, Siegmund H, Heinemann U, Manahan-Vaughan D (2006). Group III metabotropic glutamate receptor-mediated, chemically induced long-term depression differentially affects cell viability in the hippocampus. Eur. J. Pharm., 535: 104-113.
29. Nilsson M, Hansson S, Carlsson A, Carlsson ML (2007). Differential effects of the N-methyld-aspartate receptor antagonist MK801 on different stages of object recognition memory in mice. Neuroscience 149(1): 123-130.
30. Olney JW, Labruyere J, Price MT (1989). Pathological Changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362.
31. Paxinos G, Watson C (2007) The rat brain stereotaxic coordinates, 6th ed. Amsterdam, The Netherland: Academic Press.
32. Peled A (2005). Plasticity imbalance in mental disorders the neuroscience of psychiatry: implications for diagnosis and research. Med. Hypotheses 65(5): 947-952.
33. Prickaerts J, Vente J de, Honig W, Steinbusch HWM, Blokland A (2002). cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur. J. Pharmacol 436(1-2): 83-87.
34. Rujescu, D., Bender, A., Keck, M., Hartmann, A.M., Ohl, F., Raeder, H., Giegling, I., Genius, J., McCarley, R.W., Möller, H.-J. & Grunze, H. (2006) A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol. Psychiatry, 59, 721-729.
35. Stone WS, Hsi X (2011). Declarative memory deficits and schizophrenia: Problems and prospects. Neurobiol Learn Mem 96(4): 544-552.
36. Tamminga CA, Stan AD, Wagner AD (2010). The hippocampal formation in schizophrenia. Am J Psychiatry 167(10): 1178-1193.
37. van der Staay FJ, Rutten K, Erb C, Blokland A (2011). Effects of the cognition impairer MK801 on learning and memory in mice and rats. Behav. Brain Res 220(1): 215-229.
38. Wang HX, Gao WJ.(2012) Prolonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex. Neuropharmacology. 62:1808-22.
39. Wiescholleck, V. and Manahan-Vaughan, D. (2012) PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis. Transl Psychiatry, 2, e89.
40. Wöhrl R, Eisenach S, Manahan-Vaughan D, Heinemann U, Haebler D von (2007). Acute and long-term effects of MK801 on direct cortical input evoked homosynaptic and heterosynaptic plasticity in the CA1 region of the female rat. Eur. J. Neurosci 26(10): 2873-2883.
41. Wozniak, D.F., Brosnan-Watters, G., Nardi, A., McEwen, M., Corso, T.D., Olney, J.W. & Fix, A.S. (1996) MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res., 707, 165-179.
42. Vrajová M, Stastný F, Horácek J, Lochman J, Serý O, Peková S, Klaschka J, Höschl C. (2010) Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem Res.;35:994-1002.